RecruitingNCT06869668

The Relationship Between Disability, Fear Avoidance Beliefs, Physical Performance and Quality of Life in Chronic Low Back Pain


Sponsor

Istanbul Arel University

Enrollment

110 participants

Start Date

Nov 30, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study was to determine the multidimensional profile of individuals with chronic low back pain (CLBP) and to determine the relationship between disability and fear avoidance beliefs, physical performance and quality of life in this population. Individuals with chronic low back pain between the ages of 18-50 will be included in the study. Disability level of the participants will be assessed with Oswestry Disability Index (ODI), fear avoidance attitudes with Avoidance Beliefs Questionnaire-Physical Activity (FABQ-PA), and quality of life with Short Form-12 (SF-12). Trunk endurance, functional mobility and static-dynamic balance will be assessed for physical performance. Trunk endurance will be assessed with McGill endurance tests, functional mobility with Timed Up and Go Test (TUG), dynamic balance with Y-balance test, and static balance with single leg stance test.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Inclusion Criteria2

  • Back pain for at least 3 months
  • Pain intensity ≥ 3 on the Visual Analog Scale

Exclusion Criteria5

  • History of spinal surgery/trauma
  • Other back pain (associated with rheumatic diseases, multiple sclerosis, malignancy, etc.) instability conditions such as spondylolysis and spondylolisthesis
  • Pregnancy
  • Obesity (BMI ≥ 30 kg/m²)
  • Presence of orthopedic problems or chronic diseases that may interfere with testing

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCorrelation

Correlation between outcomes


Locations(1)

Istanbul University-Cerrahpasa

Istanbul, Buyukcekmece, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06869668


Related Trials